Literature DB >> 20014321

Evolution of a precursor.

Neil E Caporaso, Gerald E Marti, Robert F Vogt, Youn K Shim, Dan Middleton, Ola Landgren.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20014321      PMCID： PMC6816805          DOI： 10.1002/cyto.b.20508

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN： 1552-4949            Impact factor:   3.058


× No keyword cloud information.
  22 in total

Review 1.  Chemical exposures and risk of chronic lymphocytic leukaemia.

Authors:  Aaron Blair; Mark P Purdue; Dennis D Weisenburger; Dalsu Baris
Journal:  Br J Haematol       Date:  2007-10-24       Impact factor: 6.998

2.  Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach.

Authors:  Wendy G Nieto; Julia Almeida; Alfonso Romero; Cristina Teodosio; Antonio López; Ana F Henriques; Maria Luz Sánchez; María Jara-Acevedo; Ana Rasillo; Marcos González; Paulino Fernández-Navarro; Tomás Vega; Alberto Orfao
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

3.  B-cell clones as early markers for chronic lymphocytic leukemia.

Authors:  Ola Landgren; Maher Albitar; Wanlong Ma; Fatima Abbasi; Richard B Hayes; Paolo Ghia; Gerald E Marti; Neil E Caporaso
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

4.  Prevalence of monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Dirk R Larson; Matthew F Plevak; Janice R Offord; Angela Dispenzieri; Jerry A Katzmann; L Joseph Melton
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

5.  A genome scan of 18 families with chronic lymphocytic leukaemia.

Authors:  Lynn R Goldin; Naoko Ishibe; Maria Sgambati; Gerald E Marti; Laura Fontaine; Maxwell P Lee; Jenny M Kelley; Titia Scherpbier; Kenneth H Buetow; Neil E Caporaso
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

Review 6.  Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis.

Authors:  Martha S Linet; Mary K Schubauer-Berigan; Dennis D Weisenburger; David B Richardson; Ola Landgren; Aaron Blair; Sharon Silver; R William Field; Glyn Caldwell; Maureen Hatch; Graça M Dores
Journal:  Br J Haematol       Date:  2007-12       Impact factor: 6.998

7.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

Authors:  Andy C Rawstron; Fiona L Bennett; Sheila J M O'Connor; Marwan Kwok; James A L Fenton; Marieth Plummer; Ruth de Tute; Roger G Owen; Stephen J Richards; Andrew S Jack; Peter Hillmen
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

8.  MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?

Authors:  Tait D Shanafelt; Neil E Kay; Tim G Call; Clive S Zent; Diane F Jelinek; Betsy LaPlant; William G Morice; Curtis A Hanson
Journal:  Leuk Res       Date:  2008-01-07       Impact factor: 3.156

9.  Monoclonal B lymphocytosis in the general population.

Authors:  Antonis Dagklis; Claudia Fazi; Lydia Scarfo; Benedetta Apollonio; Paolo Ghia
Journal:  Leuk Lymphoma       Date:  2009-03

10.  B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.

Authors:  Tait D Shanafelt; Neil E Kay; Greg Jenkins; Timothy G Call; Clive S Zent; Diane F Jelinek; William G Morice; Justin Boysen; Liam Zakko; Susan Schwager; Susan L Slager; Curtis A Hanson
Journal:  Blood       Date:  2008-11-17       Impact factor: 22.113
View more
  1 in total

Review 1.  Prevalence of monoclonal B-cell lymphocytosis: a systematic review.

Authors:  Youn K Shim; Dannie C Middleton; Neil E Caporaso; Jane M Rachel; Ola Landgren; Fatima Abbasi; Elizabeth S Raveche; Andy C Rawstron; Alberto Orfao; Gerald E Marti; Robert F Vogt
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.